Caladrius Biosciences, Inc. Skyrocketed
Tue, Jul 14, 2020 at 05:30 PM
Caladrius Biosciences, Inc. (CLBS:NASDAQ) rocketted at $3, representing a gain of 38.9%. On Mon 13 Jul 20, CLBS:NASDAQ touched a New 2-Week High of $2.16. From Mon 29 Jun 20, the stock recorded 55.56% Up Days and 50.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Caladrius Biosciences, Inc. (CLBS:NASDAQ)
Caladrius Biosciences Inc is a biopharmaceutical company. The company through its subsidiary is developing cellular therapeutics to treat diseases.
Top 10 Gainers:
- Perceptron, Inc. (PRCP:NASDAQ), 107.01%
- Rigel Pharmaceuticals, Inc. (RIGL:NASDAQ), 90.97%
- INmune Bio, Inc. (INMB:NASDAQ), 77.97%
- Cleveland BioLabs, Inc. (CBLI:NASDAQ), 57.21%
- IMV Inc. (IMV:NASDAQ), 54.33%
- Dare Bioscience, Inc. (DARE:NASDAQ), 50.5%
- Vaxart, Inc. (VXRT:NASDAQ), 40.02%
- Caladrius Biosciences, Inc. (CLBS:NASDAQ), 38.89%
- Iconix Brand Group, Inc. (ICON:NASDAQ), 33.33%
- VIVUS, Inc. (VVUS:NASDAQ), 32.45%